Lv3
390 积分 2022-10-25 加入
Cefepime–Taniborbactam: A Novel Cephalosporin/β-Lactamase Inhibitor Combination
19天前
已完结
Hematological adverse events associated with anti-MRSA agents: a real-world analysis based on FAERS
26天前
已完结
Efficacy and safety of sulbactam–durlobactam versus colistin for the treatment of patients with serious infections caused by Acinetobacter baumannii–calcoaceticus complex: a multicentre, randomised, active-controlled, phase 3, non-inferiority clinical trial (ATTACK)
26天前
已完结
Efficacy and safety of sulbactam–durlobactam versus colistin for the treatment of patients with serious infections caused by Acinetobacter baumannii–calcoaceticus complex: a multicentre, randomised, active-controlled, phase 3, non-inferiority clinical trial (ATTACK)
1个月前
已完结
Cefiderocol Pharmacokinetics in Critically-ill Patients Receiving Extra-Corporeal Membrane Oxygenation (ECMO)
1个月前
已完结
In vitro activity of ceftazidime-avibactam, ceftolozane-tazobactam, imipenem-relebactam, meropenem-vaborbactam and cefiderocol against carbapenemase-producing Enterobacterales from clinical isolates in a tertiary healthcare centre in Serbia
1个月前
已关闭
Management of Highly Resistant Gram-Negative Infections in the Intensive Care Unit in the Era of Novel Antibiotics
3个月前
已关闭
Pulmonary Infection
3个月前
已关闭
Hospital-acquired bacterial pneumonia in critically ill patients: from research to clinical practice
3个月前
已完结
Eravacycline: a comprehensive review of in vitro activity, clinical efficacy, and real-world applications
3个月前
已完结
皖公网安备34019202002308
